Identification of the prognostic and therapeutic values of cyclin E1 (CCNE1) gene expression in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma: A database mining approach. Issue 9 (September 2022)

• Record Type: Journal Article
• Authors: Ullah, Md. Asad; Farzana, Maisha; Islam, Md. Shariful; Moni, Ripa; Zohora, Umme Salma; Rahman, Mohammad Shahedur
• Is Part Of: Heliyon. Volume 8:Issue 9(2022)
• Publication Date: 2022-09
• Subjects: Cyclin E1 -- CCNE1 -- Diagnosis -- Lung cancer -- Prognosis -- Therapeutic; Research -- Periodicals; Medical sciences -- Periodicals; Natural history -- Periodicals; Social sciences -- Periodicals; Earth sciences -- Periodicals; Physical sciences -- Periodicals; 507.2
• DOI: 10.1016/j.heliyon.2022.e10367
• Languages: English
• ISSNs: 2405-8440

Abstract

Abstract: Cyclin E1 ( CCNE1 ) is a protein-coding gene that belongs to the Cyclin family of genes which controls the G1/S phase transition of the cell cycle. Previously, its abnormal expression pattern has been examined and found to be correlated with ovarian and breast cancer progression. Herein, we exploited a bioinformatics and database mining strategy to unveil the therapeutic and prognostic significance of CCNE1 gene expression in Lung Adenocarcinoma (LUAD) and Lung Squamous Cell Carcinoma (LUSC). CCNE1 gene was reported to be highly expressed in LUAD and LUSC tissues. Its promoter and coding sequences were reported to be aberrantly methylated in LUAD and LUSC tissues than in normal tissues. Moreover, around 12 somatic mutations (frequency: 0.7%) were recorded in the CCNE1 coding region from different studies involving LUAD and LUSC patients' whole genome sequences. The CCNE1 gene expression was also correlated with LUAD and LUSC patients' overall and disease-specific survival. Immune infiltration analysis revealed the association between CCNE1 gene expression and the abundance of numerous immune cells (i.e., T cells and B Cells) infiltration in LUAD and LUSC patients. Two previously known genes involved in oncogenic processes i.e., CDC45 and PDCD5 were identified as the most highly co-expressed genes of CCNE1 in LUAD and LUSC tissues. Altogether, the CCNE1 gene and its transcriptional and translational products may serve as a prognostic or therapeutic target in the diagnosis and treatment of LUAD and LUSC patients. The scientific findings of this study should assist in translating CCNE1 into clinical practice for lung cancer diagnosis and treatment. Highlights: CCNE1 gene is highly expressed in LUAD and LUSC tissues CCNE1 gene is differentially methylated in LUAD and LUSC tissues CCNE1 overexpression is associated with the poor overall survival of LUAD and LUSC patients Abstract : Cyclin E1; CCNE1 ; Diagnosis; Lung cancer; Prognosis; Therapeutic.